Membrane-type 1 Matrix Metalloproteinase Modulates Tissue Homeostasis by a Non-proteolytic Mechanism

Area of Science:

• Biochemistry
• Cell Biology
• Genetics

Background:

• Membrane-type 1 matrix metalloproteinase (MT1-MMP, MMP-14) is crucial for extracellular matrix remodeling.
• Genetic defects in MT1-MMP cause dwarfism, osteopenia, arthritis, and lipodystrophy, linked to impaired collagen turnover.
• Previous studies indicated non-proteolytic roles for MT1-MMP's cytoplasmic tail, specifically tyrosine 573 (Y573), in intracellular signaling.

Purpose of the Study:

• To investigate the in vivo function of MT1-MMP's non-proteolytic activity mediated by Y573.
• To determine if MT1-MMP's cytoplasmic tail signaling influences skeletal stem cell differentiation.
• To elucidate the role of MT1-MMP in bone, cartilage, and fat homeostasis beyond its proteolytic functions.

Main Methods:

• Generation and analysis of a mouse model with a Y573D mutation in MT1-MMP (Mmp14 Y573D).
• Assessment of skeletal stem cell (SSC) differentiation in Mmp14 Y573D mice.
• Rescue experiments involving wild-type SSC transplantation into Mmp14 Y573D mice.

Main Results:

• Mice with the Mmp14 Y573D mutation exhibited phenotypes distinct from but overlapping with Mmp14 knockout mice.
• Skeletal stem cells from Mmp14 Y573D mice displayed defective differentiation.
• Transplantation of wild-type SSCs rescued the defective differentiation phenotype in Mmp14 Y573D mice.

Conclusions:

• MT1-MMP modulates bone, cartilage, and fat homeostasis through a mechanism independent of its proteolytic activity.
• The cytoplasmic tail of MT1-MMP, via Y573, controls skeletal stem cell differentiation.
• These findings provide the first in vivo evidence for MT1-MMP's non-proteolytic role in regulating tissue homeostasis.